Geno CEO Applauds Greater Government Investment at White House Summit on Biomanufacturing
WASHINGTON, Sept. 14, 2022 /PRNewswire/ -- Today, Genomatica (Geno) CEO Christophe Schilling applauded recent government investment to promote the growth of domestic biomanufacturing amid the newest White House Executive Order on emerging biotechnologies. Speaking at the White House Summit on Biotechnology and Biomanufacturing for the American Bioeconomy, Schilling reiterated that the Order will be an important driver of more resilient domestic supply chains through domestic infrastructure, delivering sustainable materials at scale, and a key component of the Biden Administration's climate resilience plan.
- WASHINGTON, Sept. 14, 2022 /PRNewswire/ -- Today, Genomatica (Geno) CEO Christophe Schilling applauded recent government investment to promote the growth of domestic biomanufacturing amid the newest White House Executive Order on emerging biotechnologies.
- "It's not often that one action fuels the economy, combats climate change and strengthens supply chains at the same time,"said Geno CEO Christophe Schilling.
- Today's Summit and Executive Order jumpstarts this process, and Geno looks forward to continued engagement with the White House to put our unique solutions to work."
- Geno already stands at the forefront of powering technologies that enable large scale biomanufacturing of sustainable materials.